about
Comparing the survival between extracorporeal rescue and conventional resuscitation in adult in-hospital cardiac arrests: propensity analysis of three-year data.Risk factors and outcome analysis after surgical management of ventricular septal rupture complicating acute myocardial infarction: a retrospective analysis.Various clinical presentations of tuberculosis in heart transplant recipients.Highlighting Indication of extracorporeal membrane oxygenation in endocrine emergencies.Extracorporeal membrane oxygenation for perioperative cardiac allograft failure.Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation.Heart transplantation in patients with extreme right ventricular failure.Heart transplantation in patients with liver cirrhosis.Review of risk factors in four cases of cryptococcosis after heart transplantation.Short-term outcomes of cadaveric lung transplantation in ventilator-dependent patients.Robotic mitral valve repair in infective endocarditis.Effect of simultaneous kidney transplantation on heart-transplantation outcome in recipients with preoperative renal dysfunction.Extracoporeal membrane oxygenation to rescue cardiopulmonary failure after heart transplantation: a single-center experience.Ventricular assist device application as a bridge to pediatric heart transplantation: a single center's experience.The outcome of heart transplantation in hepatitis C-positive recipients.Risk factors and prognosis of patients with primary graft failure after heart transplantation: an Asian center experience.Heart Transplantation Under Mechanical Circulatory Support for Acute Fulminant Myocarditis With Cardiogenic Shock: 10 Years' Experience of a Single Center.Antibody-mediated rejection after orthotopic heart transplantation: a 9-year single-institution experience.The outcome of patients requiring multiple extracorporeal membrane oxygenation: how many runs of ECMO is reasonable?Long-term Outcome of Endovascular Treatment for Mycotic Aortic Aneurysm.Low Incidence of Malignancy After Heart Transplantation in Taiwan.Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression.Clinical experience of infective endocarditis complicated by acute cerebrovascular accidents.Can cyclosporine blood level be reduced to half after heart transplantation?End-stage renal disease after orthotopic heart transplantation: a single-institute experience.The survival of heart transplant recipients using cyclosporine and everolimus is not inferior to that using cyclosporine and mycophenolate.Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience.Incorporating a pediatric concept into tricuspid valve endocarditis: one and a half ventricle repair.Surgical treatment of mediastinitis after cardiac transplantation.Fungal infection in heart transplant recipients with severe sepsis: single-center experience.Improved outcome of extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest--a comparison with that for extracorporeal rescue for in-hospital cardiac arrest.Ocular manifestations of patients receiving heart transplants: a single-center experience of 311 consecutive cases.Risk factor screening scale to optimize treatment for potential heart transplant candidates under extracorporeal membrane oxygenation.Application of papillary muscle sling concept in an infant as a biological bridge to transplantation.Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.Crossover chimney technique to preserve the internal iliac artery in abdominal aortic aneurysm with common iliac artery aneurysms.Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.Tuberculosis after heart transplantation: twenty years of experience in a single center in Taiwan.The influence of donor characteristics on survival after heart transplantation.Cardiac arrest after methylprednisolone pulse therapy rescued using extracorporeal membrane oxygenation in patients with acute cardiac rejection: two case reports.
P50
Q33562499-926BDA89-331C-4663-A912-0709DE7AC8FCQ35589303-C3513434-0B45-4C12-BFFF-CBEB875F37A2Q35961409-CFCE0FF5-D45B-4A4D-83D9-D56A448CE0F8Q35989507-286030CC-40B5-48CF-BCD0-B20308292094Q36377525-992A5B33-8545-46A1-B45A-6692D678F3EEQ36754858-7E3B2716-C018-411E-BA04-4C26EA0CD923Q36857596-DB3C1880-78D9-4841-987E-570D1A286D0BQ37186039-95D1B591-B6B1-4AAF-BBEF-654AEA47FB5AQ37302084-00AA92BD-5E58-4158-903D-F7A2530282D0Q37360353-3D872453-057E-4A1F-B394-D42E7A967E53Q37492883-604C390F-45E5-4B13-849F-434DCA1713B6Q37562118-A9CD8034-7765-455E-B202-38A09D634F89Q37739548-A242BF8E-2EAC-44B5-9584-55E9F2B76F32Q38008074-0A16B2A8-515F-451D-825D-8FA197E12F40Q38008075-D7E4A935-0863-47B2-8A98-2E982606802CQ38207232-E98A0DCC-0C07-4FB9-A1E6-7EE36BC44CAAQ38861407-F65C5A9B-4D59-4255-8691-7FC6F37370D2Q39203311-736CB98B-86C0-4F32-9952-6E9C576EA400Q39575347-75A96095-BFF4-4048-A64E-85BFD25E0450Q40085372-A2C2FC3C-DCCB-4025-BE60-92244DC606D8Q40731372-25BD5856-A1B4-41C8-88FA-EA9CE666C601Q40731379-6C33C84D-997D-48B0-BAE0-9A6D1D26BF11Q40893775-B1FCF3F7-2917-41D3-BDBC-379AF8FB65AEQ42658761-85E4CF77-3A59-4290-8E1B-6DCBAD82A5D0Q43079838-A4D04014-C1E5-46C3-9BC4-6BE70ED47D17Q43079845-78570D90-476B-44D5-8330-42F076D1D8CCQ43079848-A649F147-83A2-46B6-B320-1F34E43A169EQ43491017-5D08AC98-075F-4625-A86A-F9045365E381Q44163710-BD65E570-E8E9-4D0C-89D9-7495E8D25868Q44233682-8ADF8923-F99C-4C3F-964F-7D961FA43095Q44420218-041F40F3-9FA6-4D69-B0CB-E4FF2ABC9324Q45058433-9EDA68E7-15DE-4682-A116-B6826E8AF691Q45100313-4A7F7EC7-31B0-494A-A50F-399662B6B9BDQ45203167-E05D0FFF-8D6C-4EB5-8ED7-5C56B8763ED9Q45357787-A12F5933-BB47-45D2-A7D4-FC8B37C4F067Q45385322-5681AA0E-9609-4184-AC4E-BDFF4BCB0D11Q45412086-255AA9A8-D916-4236-BE10-F1B1FA9FE22CQ45910195-76FB35DB-3136-4D0E-8146-9C713251B8F2Q46310987-0B74C7F1-77E3-450F-9834-A4EDD1BB7331Q46311002-6B899F5E-4B0E-43BE-B1BA-043E76A99215
P50
description
researcher ORCID 0000-0003-1829-6084
@en
wetenschapper
@nl
name
Nai-Hsin Chi
@ast
Nai-Hsin Chi
@en
Nai-Hsin Chi
@es
Nai-Hsin Chi
@nl
type
label
Nai-Hsin Chi
@ast
Nai-Hsin Chi
@en
Nai-Hsin Chi
@es
Nai-Hsin Chi
@nl
prefLabel
Nai-Hsin Chi
@ast
Nai-Hsin Chi
@en
Nai-Hsin Chi
@es
Nai-Hsin Chi
@nl
P108
P106
P1153
7006655638
P31
P496
0000-0003-1829-6084